相关实验视频

Updated: Jul 5, 2025

Microfluidic Co-Culture Models for Dissecting the Immune Response in in vitro Tumor Microenvironments

Microfluidic Co-Culture Models for Dissecting the Immune Response in in vitro Tumor Microenvironments

Published on: April 30, 2021

对于先天免疫媒介瘤微环境重塑的工程方法

G I Kane^1,2, C F Lusi^1,2, M L Brassil^1,2

¹Department of Biomedical Engineering, University of Massachusetts Amherst, Amherst.

Immuno-oncology technology

|January 12, 2024

概括

癌症免疫疗法正在发展到超越T细胞,激活先天性免疫细胞. 工程方法提高了瘤微环境 (TME) 改造的交付和有效性,以对抗致命的癌症.

科学领域:

在瘤学瘤学.
免疫学免疫学免疫学
生物医学工程生物医学工程

背景情况:

针对T细胞的癌症免疫疗法在固体瘤中表现出有限的疗效,原因是免疫抑制性瘤微环境 (TME).
激活像树突细胞和巨细胞这样的先天性免疫细胞可以促进促炎反应,以重塑TME从"冷"到"热".

研究的目的:

审查先天免疫媒介瘤微环境 (TME) 改造的工程方法.
突出提高TME调节疗法的交付和疗效的策略.

主要方法:

工程策略的审查,包括治疗剂的封装,向和联合递送.
专注于先天免疫激动剂,免疫原病毒和基于细胞的TME重塑方法.

主要成果:

工程方法提高了天生的免疫激活剂的输送和有效性.
策略旨在克服与自由细胞因子和激动剂相关的全身毒性和非目标炎症.

结论:

天生的免疫媒介TME重塑为增强癌症免疫治疗提供了一个有前途的范式.
工程策略对于开发对固体瘤的有效和安全治疗至关重要.

关键词:

抗体与药物结合物的结合物.细胞工程细胞工程细胞治疗疗法细胞治疗疗法树突细胞是一种树突细胞.免疫细胞因子免疫细胞因子治疗性疫苗治疗性疫苗

更多相关视频

Evaluation of Tumor-infiltrating Leukocyte Subsets in a Subcutaneous Tumor Model

Evaluation of Tumor-infiltrating Leukocyte Subsets in a Subcutaneous Tumor Model

Published on: April 13, 2015

Studying the Effects of Tumor-Secreted Paracrine Ligands on Macrophage Activation using Co-Culture with Permeable Membrane Supports

Studying the Effects of Tumor-Secreted Paracrine Ligands on Macrophage Activation using Co-Culture with Permeable Membrane Supports

Published on: November 28, 2019

相关概念视频

The Tumor Microenvironment

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.